Skip to search formSkip to main content

A 56620

Known as: A-56620 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Sarafloxacin (formerly A-56620) is a fluoroquinolone recently introduced into veterinary practice for the therapy of… Expand
Is this relevant?
1987
1987
A rabbit model for Staphylococcus aureus osteomyelitis was used to compare the results of treatment with A-56619 and A-56620, two… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
1987
1987
The new fluorinated quinolones display interesting but variable activity against mycobacteria. Almost all compounds tested… Expand
Is this relevant?
1987
1987
Most antibacterial agents do not affect human lymphocyte function, but a few are inhibitory. In contrast, a pronounced increase… Expand
Is this relevant?
1986
1986
The in vitro antibacterial potencies of A-56619 and A-56620, two new aryl-fluoroquinolones, were compared with the potency of… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1986
1986
Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 were found to inhibit human peripheral blood mononuclear cell… Expand
Is this relevant?
1986
1986
The in-vitro antibacterial activity of nalidixic acid and the 4-quinolones, ciprofloxacin, norfloxacin, enoxacin, ofloxacin… Expand
Is this relevant?
1986
1986
The in vitro activities of two new aryl-fluoroquinolones (A-56619 and A-56620) were compared with those of ciprofloxacin… Expand
Is this relevant?
1986
1986
A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered… Expand
Is this relevant?
1985
1985
The in vitro activities of two new quinolone antimicrobial agents, A-56619 and A-56620, were compared with those of norfloxacin… Expand
Is this relevant?